DELAYED ELIMINATION OF TRIAMTERENE AND ITS ACTIVE METABOLITE IN CHRONIC-RENAL-FAILURE

被引：20

作者：

KNAUF, H

MOHRKE, W

MUTSCHLER, E

机构：

[1] UNIV FRANKFURT,INST PHARMACOL,DEPT PHARM & BIOCHEM,D-6000 FRANKFURT 70,FED REP GER

[2] UNIV FREIBURG,DEPT MED,D-7800 FREIBURG,FED REP GER

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1983年 / 24卷 / 04期

关键词：

D O I：

10.1007/BF00609885

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：453 / 456

页数：4

共 14 条

[1]

BABA W I, 1962, Br Med J, V2, P756

[2]

BABA WI, 1968, CLIN PHARMACOL THER, V9, P318

[3]

DETTLI L, 1976, Clinical Pharmacokinetics, V1, P126, DOI 10.2165/00003088-197601020-00004

[4]

GREBIAN B, 1978, ARZNEIMITTEL-FORSCH, V28-2, P1420

[5]

GREBIAN B, 1976, ARZNEIMITTEL-FORSCH, V26, P2125

[6] INFLUENCE OF HEPATIC CIRRHOSIS AND END-STAGE RENAL-DISEASE ON PHARMACOKINETICS AND PHARMACODYNAMICS OF FUROSEMIDE [J].

KELLER, E ;

HOPPESEYLER, G ;

MUMM, R ;

SCHOLLMEYER, P .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 20 (01) :27-33

[7] MECHANISM OF ACTION OF TRIAMTERENE - EFFECTS ON TRANSPORT OF NA+, K+, AND H+-HCO-3-IONS [J].

KNAUF, H ;

WAIS, U ;

LUBCKE, R ;

ALBIEZ, G .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1976, 6 (01) :43-50

[8]

KNAUF H, 1978, ARZNEIMITTEL-FORSCH, V28-2, P1417

[9]

KNAUF H, 1976, THERAPIEWOCHE, V26, P5384

[10]

KNAUF H, 1983, UNPUB EUR J CLIN PHA

← 1 2 →